Tag - BMS

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

2019 in Review – Major Acquisitions, Population Studies, Gigantic Founding Rounds, Technological Advancements, and ….

Immunotherapy and the Basis of Neoantigen Biology: Part II Cancer Immunotherapies

BioIT 2019: The New “Official” Future Involves Data Sharing, Artificial Intelligence, Open Source, and More

JP Morgan 2019 – Drug pricing, drug development, immunotherapy, cancer moonshot, cell/gene-therapy, …

Copyright © 2026. enlighenbio LLC. All rights reserved.